₹1,606.40
+₹25.40 (+1.61%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹3,702 Cr
P/E
72.03
ROE
5.38%
ROCE
6.63%
About Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem is primarily engaged in manufacturing, sale and distribution of specialty chemicals, viz., phase transfer catalysts (PTC), structure directing agents (SDA), electrolyte salts and solutions (ESS), pharmaceutical and agrochemical i
Founded
1996
CEO
Chintan Nitinkumar Shah
Employees
939
HQ
Vadodara, India
About Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem is primarily engaged in manufacturing, sale and distribution of specialty chemicals, viz., phase transfer catalysts (PTC), structure directing agents (SDA), electrolyte salts and solutions (ESS), pharmaceutical and agrochemical i
Founded:1996
CEO:Chintan Nitinkumar Shah
Employees:939
HQ:Vadodara, India
Finished Products
1Sale of products
₹739.27Cr2Scrap
₹4.09Cr3Export incentives
₹1.74CrRaw Materials
1Cost of Materials Consumed
₹352.53CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,838
52W Low
₹976
Volume27.43K
Avg VolumeN/A
Beta1.25
Dividend Yield0.13%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
72.03x
Valuation
P/B Ratio
4.74x
Valuation
EPS
₹21.97
Valuation
Dividend Yield
0.13%
Valuation
ROE
5.38%
Profitability
ROCE
6.63%
Profitability
Revenue by Segment
Contribution & growth by business line
Specialty Chemical BusinessRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
38.0%
International
62.0%
Overseas62.0%
Domestic38.0%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.15x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
-3.3%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.